Patents by Inventor Beatrice KNUDSEN

Beatrice KNUDSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of classifying and diagnosing cancer
    Patent number: 11174518
    Abstract: The invention provides various methods for classifying prostate cancers into subtypes. The classification methods may be used to diagnose or prognose prostate cancers. In one embodiment, the subtypes are PCS1, PCS2, or PCS3. In one embodiment, the PCS1 subtype is most likely to progress to metastatic disease or prostate cancer specific mortality when compared to the PCS2 subtype or PCS3 subtype. In one embodiment, the PCS1 subtype is resistant to enzalutamide.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: November 16, 2021
    Assignee: Cedars-Sinai Medical Center
    Inventors: Sungyong You, Michael Freeman, Jayoung Kim, Beatrice Knudsen
  • Automated delineation of nuclei for three dimensional (3-D) high content screening
    Patent number: 10733417
    Abstract: In various embodiments, the invention teaches systems and methods for analyzing an image of cells, including an image obtained by confocal microscopy, and delineating cell nuclei in the image. In some embodiments, the systems and methods apply a three-dimensional (3-D) radial symmetry transform followed by adaptive post processing of symmetry images to arrive at a mask of seeds that can guide watershed-based segmentation.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: August 4, 2020
    Assignee: Cedars-Sinai Medical Center
    Inventors: Arkadiusz Gertych, Beatrice Knudsen
  • METHOD OF CLASSIFYING AND DIAGNOSING CANCER
    Publication number: 20180282817
    Abstract: The invention provides various methods for classifying prostate cancers into subtypes. The classification methods may be used to diagnose or prognose prostate cancers. In one embodiment, the subtypes are PCS1, PCS2, or PCS3. In one embodiment, the PCS1 subtype is most likely to progress to metastatic disease or prostate cancer specific mortality when compared to the PCS2 subtype or PCS3 subtype. In one embodiment, the PCS1 subtype is resistant to enzalutamide.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 4, 2018
    Applicant: Cedars-Sinai Medical Center
    Inventors: Sungyong YOU, Michael FREEMAN, Jayoung KIM, Beatrice KNUDSEN
  • AUTOMATED DELINEATION OF NUCLEI FOR THREE DIMENSIONAL (3-D) HIGH CONTENT SCREENING
    Publication number: 20180075279
    Abstract: In various embodiments, the invention teaches systems and methods for analyzing an image of cells, including an image obtained by confocal microscopy, and delineating cell nuclei in the image. In some embodiments, the systems and methods apply a three-dimensional (3-D) radial symmetry transform followed by adaptive post processing of symmetry images to arrive at a mask of seeds that can guide watershed-based segmentation.
    Type: Application
    Filed: April 22, 2016
    Publication date: March 15, 2018
    Applicant: Cedars-Sinai Medical Center
    Inventors: Arkadiusz GERTYCH, Beatrice KNUDSEN